ArticleJournal of the American Heart Association2021

Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Parvin Forghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.